RT Journal Article
SR Electronic
T1 <sup>18</sup>F-FDG PET/CT imaging features of Cardiac Arrhythmia - induced by Panitumumab
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP jnmt.121.262216
DO 10.2967/jnmt.121.262216
A1 Pokhraj Prakashchandra Suthar
A1 Khushboo Gupta
A1 Jagadeesh S Singh
YR 2021
UL http://tech.snmjournals.org/content/early/2021/07/30/jnmt.121.262216.abstract
AB Panitumumab is a new humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) approved for the treatment of advanced colorectal cancer. There is an increase in the use of this drug due to a good response rate and possible secondary resection in advance colorectal cancer. Here we present 18F-FDG PET/CT imaging findings of cardiac arrhythmia in a patient receiving Panitumumab for the treatment of metastatic infiltrating rectal adenocarcinoma. Cardiotoxicity is a known adverse effect associated with Panitumumab. By far to our knowledge, no documented imaging findings for the same are available in the literature.